Feasibility of whole-genome sequencing using cytology samples for cancer genomic analysis: a pilot study with xenograft and clinical samples

Abstract Background Whole-genome sequencing (WGS) offers comprehensive genomic profiling but generally requires high-quality nucleic acids from fresh-frozen (FF) tissue. For broader application of genome-scale cancer analysis, more readily available sample types are needed. Cytology samples may provide better nucleic acid quality than formalin-fixed paraffin-embedded tissue and therefore represent a potential alternative source for WGS. We evaluated the feasibility of WGS using cytology samples by comparison with matched FF samples. Methods WGS and RNA sequencing were performed using cytology and FF tumor samples from a HER2-positive BT-474 xenograft model and a patient with endometrioid carcinoma. Concordance of SNV, CNA, and SV findings between cytology and FF samples was assessed. Results For SNVs, filtering with variant allele frequency ≧ 0.1 yielded nearly 90% concordance between patient FF and cytology samples. For CNAs, ERBB2 amplification was detected in xenograft-derived cytology samples, supporting the utility of cytology samples for copy number analysis, although no clinically relevant CNAs were identified in the clinical sample. Structural variant analysis showed limited concordance. Conclusions Cytology samples may represent a feasible alternative source for WGS-based short-variant analysis when fresh-frozen tissue is unavailable, whereas CNA and especially structural variant detection require further optimization and complementary approaches.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11226628/v1
Primary Topic
Cancer Genomics and Diagnostics
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Feasibility of whole-genome sequencing using cytology samples for cancer genomic analysis: a pilot study with xenograft and clinical samples

Kanako C. Hatanaka, Hiroyuki Yamazaki, Hidemichi Watari, Ichiro Kinoshita et al.
Research Square
Cancer Genomics and Diagnostics
preprint

Feasibility of whole-genome sequencing using cytology samples for cancer genomic analysis: a pilot study with xenograft and clinical samples

Kanako C. Hatanaka, Hiroyuki Yamazaki, Hidemichi Watari, Ichiro Kinoshita, Yoshiki Shinomiya, Asami Okumura, Ayae Nange, Kotoe Katayama, Yutaka Hatanaka, Tôru Kondo, Hiroshi Asano, Seiya Imoto
preprint en

Abstract

Abstract Background Whole-genome sequencing (WGS) offers comprehensive genomic profiling but generally requires high-quality nucleic acids from fresh-frozen (FF) tissue. For broader application of genome-scale cancer analysis, more readily available sample types are needed. Cytology samples may provide better nucleic acid quality than formalin-fixed paraffin-embedded tissue and therefore represent a potential alternative source for WGS. We evaluated the feasibility of WGS using cytology samples by comparison with matched FF samples. Methods WGS and RNA sequencing were performed using cytology and FF tumor samples from a HER2-positive BT-474 xenograft model and a patient with endometrioid carcinoma. Concordance of SNV, CNA, and SV findings between cytology and FF samples was assessed. Results For SNVs, filtering with variant allele frequency ≧ 0.1 yielded nearly 90% concordance between patient FF and cytology samples. For CNAs, ERBB2 amplification was detected in xenograft-derived cytology samples, supporting the utility of cytology samples for copy number analysis, although no clinically relevant CNAs were identified in the clinical sample. Structural variant analysis showed limited concordance. Conclusions Cytology samples may represent a feasible alternative source for WGS-based short-variant analysis when fresh-frozen tissue is unavailable, whereas CNA and especially structural variant detection require further optimization and complementary approaches.

Research Square
Hokkaido University (JP), Hokkaido University Hospital (JP), The University of Tokyo (JP)
Japan Agency for Medical Research and Development
Good health and well-being
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon